World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
16452
World Ranking
18935
National Ranking
9439

Overview

Richard G. Stock is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily focuses on medical fields related to cancer treatment, particularly prostate cancer, with extensive work in radiation therapy and oncology.

The research output of Richard G. Stock covers several main fields and subfields of study:

  • Medicine
  • Pulmonary and Respiratory Medicine
  • Radiation
  • Oncology
  • Cancer Research
  • Radiology, Nuclear Medicine and Imaging

Their work incorporates a broad range of topics centered on cancer and radiotherapy, including:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Advanced Radiotherapy Techniques
  • Bladder and Urothelial Cancer Treatments
  • Radiopharmaceutical Chemistry and Applications
  • Cancer, Lipids, and Metabolism
  • Effects of Radiation Exposure

Several frequent publication venues have featured their work, highlighting consistent contributions to peer-reviewed journals important in the oncology and radiation therapy communities:

  • Brachytherapy
  • International Journal of Radiation Oncology*Biology*Physics
  • Radiotherapy and Oncology
  • Journal of Clinical Oncology
  • The Journal of Urology

Recent papers authored or co-authored by Richard G. Stock include:

  • "A biochemical definition of cure after brachytherapy for prostate cancer," 2020, Radiotherapy and Oncology
  • "Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement," 2021, Brachytherapy
  • "Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer," 2022, JAMA Oncology
  • "Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity," 2021, Radiotherapy and Oncology
  • "A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort," 2020, Frontiers in Oncology

Collaborations are a key component of their research, with frequent co-authors including:

  • Gregory S. Merrick
  • Brian J. Moran
  • Eric M. Horwitz
  • Barry S. Rosenstein
  • J.K. Wong

Best Publications

  • A dose-response study for I-125 prostate implants

    R G Stock;N N Stone;A Tabert;C Iannuzzi

  • Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.

    Peter Grimm;Ignace Billiet;David Bostwick;Adam P Dicker

  • The american brachytherapy society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis

    Subir Nag;William Bice;Keith DeWyngaert;Bradley Prestidge

  • American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy

    Brian J. Davis;Eric M. Horwitz;W. Robert Lee;Juanita M. Crook

  • IDENTIFICATION OF PATIENTS AT INCREASED RISK FOR PROLONGED URINARY RETENTION FOLLOWING RADIOACTIVE SEED IMPLANTATION OF THE PROSTATE

    Mitchell D. Terk;Richard G. Stock;Nelson N. Stone

  • A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation

    Richard G. Stock;Nelson N. Stone;Michael F. Wesson;J.Keith DeWyngaert

  • Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results.

    Richard G. Stock;Nelson N. Stone;Jamie A. Cesaretti;Barry S. Rosenstein

  • Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.

    Amar U. Kishan;Ryan R. Cook;Jay P. Ciezki;Ashley E. Ross

  • Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis.

    Kurt M Snyder;Richard G Stock;Suzanne M Hong;Yeh Chi Lo

  • Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society.

    Subir Nag;Jay P Ciezki;Robert Cormack;Stephen Doggett

  • LAPAROSCOPIC PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER: COMPARISON OF THE EXTENDED AND MODIFIED TECHNIQUES

    Nelson N. Stone;Richard G. Stock;Pamela Unger

  • PENILE ERECTILE FUNCTION AFTER PERMANENT RADIOACTIVE SEED IMPLANTATION FOR TREATMENT OF PROSTATE CANCER

    Richard G. Stock;Johnny Kao;Nelson N. Stone

  • Complications following permanent prostate brachytherapy

    N.N. Stone;R.G. Stock

  • Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: Importance of patient selection and implant quality

    Marisa A Kollmeier;Richard G Stock;Nelson Stone

  • Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.

    Sarah L. Kerns;Harry Ostrer;Richard Stock;William Li

  • Long-Term Outcome and Toxicity of Salvage Brachytherapy for Local Failure After Initial Radiotherapy for Prostate Cancer

    Ryan J. Burri;Nelson N. Stone;Pam Unger;Richard G. Stock

  • Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation.

    Lucille N Lee;Richard G Stock;Nelson N Stone

  • Multicenter Analysis of Effect of High Biologic Effective Dose on Biochemical Failure and Survival Outcomes in Patients With Gleason Score 7–10 Prostate Cancer Treated With Permanent Prostate Brachytherapy

    Nelson N. Stone;Louis Potters;Brian J. Davis;Jay P. Ciezki

  • A 30-Year Experience in the Management of Primary Carcinoma of the Vagina: Analysis of Prognostic Factors and Treatment Modalities

    Richard G. Stock;Alex S.J. Chen;Jan Seski

  • Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications.

    Richard G Stock;Nelson N Stone;Jamie A Cesaretti

Frequent Co-Authors

Michael J. Zelefsky
Michael J. Zelefsky Memorial Sloan Kettering Cancer Center
Eric M. Horwitz
Eric M. Horwitz Fox Chase Cancer Center
Harry Ostrer
Harry Ostrer Albert Einstein College of Medicine
William Oh
William Oh Icahn School of Medicine at Mount Sinai
Phuoc T. Tran
Phuoc T. Tran Johns Hopkins University School of Medicine
Dirk De Ruysscher
Dirk De Ruysscher Maastricht University
Michael W. Kattan
Michael W. Kattan Cleveland Clinic
Mack Roach
Mack Roach University of California, San Francisco
Daniel E. Spratt
Daniel E. Spratt University of Michigan–Ann Arbor
Patrick A. Kupelian
Patrick A. Kupelian University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t always mean following the classic path of becoming a physician. Today, a range of online health degrees open diverse pathways—for both clinical and non-clinical roles—offering flexibility and accessibility.

For those interested in leadership or administrative roles, pursuing a health care administration online degree provides a strong foundation. These programs are designed to equip students with management skills for hospitals, clinics, and public health organizations.

If you’re seeking advanced leadership positions, the cheapest mha programs (Master of Healthcare Administration) offer affordable routes to obtaining in-depth expertise in healthcare systems and policy.

For nurses aiming to reach the highest clinical practice levels, consider the cheapest dnp programs (Doctor of Nursing Practice). These flexible online options help advance careers without sacrificing current commitments.

Finally, pharmacists can benefit from modern online pharmacy school programs, streamlining the route to a doctorate and expanding options in research, clinical practice, or pharmaceutical administration.

Best Scientists Citing Richard G. Stock

Trending Scientists